DIALYSIS · CCN 052852

DaVita Crescent Heights Dialysis Center

Los Angeles, CA 90048

DialysisProfitDaVita
$7.5M
TOTAL REVENUE
28.2%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$7.5M
Total costs
$5.4M
Operating income (rev − costs)
$2.1M
Operating margin
28.2%
Total charges
$5.7M
Total treatments
14,966
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.47171—
Fistula Rate
DFC_FISTULA_RATE
61.7112—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.243—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
121.1101—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.82——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
16112—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
14.6413—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
18.786—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
29.692—
Standardized ED Visits Ratio
DFC_SEDR
0.4280—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
16.369—